MENU
PBYI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Puma Biotechnology (PBYI) Earnings Date & Reports

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

PBYI is expected to report earnings to rise 30.71% to 27 cents per share on February 26

Puma Biotechnology PBYI Stock Earnings Reports
Q4'25
Est.
$0.27
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.06
Q4'24
Beat
by $0.32
Q3'24
Beat
by $0.13
The last earnings report on November 06 showed earnings per share of 20 cents, beating the estimate of 15 cents. With 657.16K shares outstanding, the current market capitalization sits at 249.44M.
View a ticker or compare two or three
PBYI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PBYI showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10880 Wilshire Boulevard
Phone
+1 424 248-6500
Employees
185
Web
http://www.pumabiotechnology.com